• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Heartbeam Inc (NQ: BEAT )

    2.400 +0.110 (+4.80%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 21, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 78,063
    Open 2.280
    Bid (Size) 2.210 (5)
    Ask (Size) 2.470 (19)
    Prev. Close 2.290
    Today's Range 2.200 - 2.420
    52wk Range 1.060 - 3.740
    Shares Outstanding 34,260,799
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces Positive Study Data for Its AI Program
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias
    From HeartBeam, Inc.
    Via Business Wire

    Performance

    YTD
    +3.00%
    +3.00%
    1 Month
    +1.69%
    +1.69%
    3 Month
    +12.15%
    +12.15%
    6 Month
    +14.29%
    +14.29%
    1 Year
    +5.26%
    +5.26%

    More News

    Read More
    BioMedNewsBreaks — HeartBeam Inc.’s (NASDAQ: BEAT) AIMIGo(TM) Recognized as ‘Best New ECG Technology Solution’ in Awards Program
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    BEAT Stock Earnings: HeartBeam Meets EPS for Q4 2023
    Via InvestorPlace
    HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program
    From HeartBeam, Inc.
    Via Business Wire
    BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q1 2024 Financial, Operational Report
    Via Investor Brand Network
    Topics Artificial Intelligence Intellectual Property
    Exposures Artificial Intelligence Intellectual Property Product Safety
    Recap: HeartBeam Q4 Earnings
    Via Benzinga
    A Preview Of HeartBeam's Earnings
    Via Benzinga
    TechMediaBreaks – HeartBeam Inc. (NASDAQ: BEAT) Releases Q1 2024 Financial, Operational Report
    Via Investor Brand Network
    Topics Artificial Intelligence Intellectual Property
    Exposures Artificial Intelligence Intellectual Property Product Safety
    BEAT Stock Earnings: HeartBeam Misses EPS for Q1 2024
    Via InvestorPlace
    HeartBeam Reports First Quarter 2024 Results
    From HeartBeam, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Schedules Conference Call to Discuss Q1 2024 Results
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time
    From HeartBeam, Inc.
    Via Business Wire
    BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Presents Key Data in First-Ever Scientific Presentation of Proprietary HeartBeam AI
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias
    From HeartBeam, Inc.
    Via Business Wire
    Why FedEx Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Financial Results, Corporate Highlights for Q4, FY 2023
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property Product Safety
    HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results
    From HeartBeam, Inc.
    Via Business Wire
    Earnings Scheduled For March 20, 2024
    Via Benzinga
    BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Enrolls First Patients in Key Study Assessing Proprietary AIMIGo(TM) System
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence Product Safety
    First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo™ System for Synthesizing a 12-Lead ECG
    From HeartBeam, Inc.
    Via Business Wire
    What's Going On With Heartbeam (BEAT) Stock?
    Via Benzinga
    BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Awarded Two New US Patents Covering Core Cardiac Monitoring Technology
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.